Status:
COMPLETED
Induction Related BK Viremia in Renal Transplant Patients
Lead Sponsor:
University of Florida
Collaborating Sponsors:
Novartis Pharmaceuticals
Conditions:
Disease Due to BK Polyomavirus
Transplantation Infection
Eligibility:
All Genders
18-75 years
Brief Summary
The increase immunosuppression in our transplant population has led to an unacceptable rate of patients at risk for BK virus nephropathy. Reducing induction immunosuppression by switching from Thymogl...
Detailed Description
Our standard of care has been changed from Thymoglobulin to Simulect and now patients were enrolled in this observational trial to gather data on their outcomes related to BK viremia and rejection rat...
Eligibility Criteria
Inclusion
- De novo transplant
- Aged 18-75
Exclusion
- Serious medical condition which, in the opinion of the Principal Investigator, might interfere with the subject's ability to successfully complete the protocol.
- Any medical condition which, in the opinion of the Principal Investigator, might compromise the safety of the subject in participating in the protocol
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00610961
Start Date
October 1 2007
End Date
November 1 2009
Last Update
September 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610